Elevation Oncology Inc. (Nasdaq: ELEV) is being bought out by Concentra Biosciences for $0.36 in cash per share, plus a ...

“While we would have preferred to reach an agreement privately, Cycle is publicly disclosing our proposal for the benefit of Vanda shareholders,” said the Cambridge, UK-headquartered compan ...

Gilead Sciences has refiled for FDA approval of its HIV capsid inhibitor lenacapavir – which only needs to be dosed every six months – after the drug was rejected by the regulator in February.

EXCLUSIVE How DOES Elizabeth Hurley look so good at 60? Secrets behind the actress's eternal youth as she shows off her 'birthday suit' in sultry snap One of the original 'It girls', Elizabeth ...

Fable Therapeutics, a discovery-stage biotechnology company developing purpose-built biologics powered by state-of-the-art structure and sequence-based protein language models, today announced the ...

A more sustainable future facilitated by the transforming power of chemistry.